Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | GABRP | O00591 | 2/20 | 0.33 |
| ▸ | GABRD | O14764 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Malonic Acid SCHEMBL4864852 | 0.86 | LDHA (0.53) | FFAR3TP53LDHASRRSLC22A6 | |
| Succinic Acid SCHEMBL5874469 | 0.83 | EGLN1 (0.50) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Propionic Acid SCHEMBL357729 | 0.83 | FFAR3 (0.56) | FFAR3TP53SLC22A6HDAC3HDAC1 | |
| Butyric Acid SCHEMBL5874265 | 0.82 | FFAR3 (0.62) | FFAR3SLC22A6HDAC3HDAC1HDAC2 | |
| Bicarbonate SCHEMBL5874276 | 0.82 | TP53 (0.47) | FFAR3TP53CYP2D6CYP2C19ALDH1A1 | |
| Propionic Acid SCHEMBL27791535 | 0.82 | — | — | |
| Chloroacetic Acid SCHEMBL5874831 | 0.81 | TSHR (0.53) | FFAR3TP53LDHASRRSLC22A6 | |
| Glycine SCHEMBL3747355 | 0.81 | GLRA1 (0.53) | TP53LDHASRRSLC22A6CYP2D6 | |
| Propionic Acid SCHEMBL21145096 | 0.80 | FFAR3 (0.59) | FFAR3TP53HDAC3HDAC1HDAC2 | |
| Propionic Acid SCHEMBL27910383 | 0.79 | FFAR3 (0.67) | FFAR3TP53SLC22A6HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240138403-A1 | Synergistic Combinations for Reducing Volatility of Auxin Herbicides | ETHOX CHEMICALS, LLC | 2024-05-02 | — | — | US | claimed |
| US-20230021295-A1 | Synergistic Combinations for Reducing Volatility of Auxin Herbicides | ETHOX CHEMICALS, LLC | 2023-01-19 | — | — | US | claimed |
| WO-2023278670-A1 | SYNERGISTIC COMBINATIONS FOR REDUCING VOLATILITY OF AUXIN HERBICIDES | ETHOX CHEMICALS, LLC (US) | 2023-01-05 | — | — | WO | claimed |
| US-20240138403-A1 | Synergistic Combinations for Reducing Volatility of Auxin Herbicides | ETHOX CHEMICALS, LLC | 2024-05-02 | — | — | US | disclosed |
| US-20230021295-A1 | Synergistic Combinations for Reducing Volatility of Auxin Herbicides | ETHOX CHEMICALS, LLC | 2023-01-19 | — | — | US | disclosed |
| WO-2023278670-A1 | SYNERGISTIC COMBINATIONS FOR REDUCING VOLATILITY OF AUXIN HERBICIDES | ETHOX CHEMICALS, LLC (US) | 2023-01-05 | — | — | WO | disclosed |
| US-20140348959-A1 | Formulations and Methods for Treating Ear Conditions | PARTICLE SCIENCES, INC. | 2014-11-27 | — | — | US | disclosed |
| WO-2013123249-A2 | FORMULATIONS AND METHODS FOR TREATING EAR CONDITIONS | PARTICLE SCIENCES, INC. (US) | 2013-08-22 | — | — | WO | disclosed |
| EP-1928439-A4 | METHODS FOR TREATMENT AND PREVENTION OF OTITIS MEDIA USING CHEMICAL PENETRATION ENHANCERS TO FACILITATE TRANSMEMBRANE DRUG DELIVERY INTO THE MIDDLE EAR | PIEDMONT PHARMACEUTICALS LLC (US) | 2009-04-29 | — | — | EP | disclosed |
| US-20080318918-A1 | Methods for Treatment and Prevention of Otitis Media Using Nonionic Surfactants to Facilitate Transmembrane Drug Delivery into the Middle Ear | PIEDMONT PHARMACEUTICALS LLC | 2008-12-25 | — | — | US | disclosed |
| US-20080269187-A1 | Methods for Treatment and Prevention of Otitis Media Using Chemical Penetration Enhancers to Facilitate Transmembrane Drug Delivery Into the Middle Ear | PIEDMONT PHARMACEUTICALS LLC | 2008-10-30 | — | — | US | disclosed |
| CN-1674870-A | Liposomes containing biologically active compounds | PIEDMONT PHARMACEUTICALS LLC (US) | 2005-09-28 | — | — | CN | disclosed |
| EP-1515698-A4 | LIPOSOMES CONTAINING BIOLOGICALLY ACTIVE COMPOUNDS | PIEDMONT PHARMACEUTICALS LLC (US) | 2005-09-14 | — | — | EP | disclosed |
| EP-1515698-A2 | LIPOSOMES CONTAINING BIOLOGICALLY ACTIVE COMPOUNDS | Piedmont Pharmaceuticals, LLC (US) | 2005-03-23 | — | — | EP | disclosed |
| WO-2004000226-A2 | LIPOSOMES CONTAINING BIOLOGICALLY ACTIVE COMPOUNDS | PIEDMONT PHARMACEUTICALS, LLC (US) | 2003-12-31 | — | — | WO | disclosed |
| US-20030235610-A1 | Liposomes containing biologically active compounds | PIEDMONT PHARMACEUTICALS, LLC | 2003-12-25 | — | — | US | disclosed |
| US-20030091838-A1 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2003-05-15 | — | — | US | disclosed |
| EP-0370491-B1 | Liposome comprising a novel phosphate as membrane constituent, liposome preparations and cosmetic preparations comprising said phosphate | KAO CORP (JP) | 1995-04-19 | — | — | EP | disclosed |
| US-5153000-A | Moisture retaining | KAO CORPORATION (JP) | 1992-10-06 | — | — | US | disclosed |
| EP-0370491-A2 | Liposome comprising a novel phosphate as membrane constituent, liposome preparations and cosmetic preparations comprising said phosphate | KAO CORPORATION (JP) | 1990-05-30 | — | — | EP | disclosed |